Cargando…
Use of AI to assess COVID-19 variant impacts on hospitalization, ICU, and death
The rapid spread of COVID-19 and its variants have devastated communities worldwide, and as the highly transmissible Omicron variant becomes the dominant strain of the virus in late 2021, the need to characterize and understand the difference between the new variant and its predecessors has been an...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748260/ https://www.ncbi.nlm.nih.gov/pubmed/36530359 http://dx.doi.org/10.3389/frai.2022.927203 |
_version_ | 1784849787982446592 |
---|---|
author | Hilal, Waleed Chislett, Michael G. Snider, Brett McBean, Edward A. Yawney, John Gadsden, S. Andrew |
author_facet | Hilal, Waleed Chislett, Michael G. Snider, Brett McBean, Edward A. Yawney, John Gadsden, S. Andrew |
author_sort | Hilal, Waleed |
collection | PubMed |
description | The rapid spread of COVID-19 and its variants have devastated communities worldwide, and as the highly transmissible Omicron variant becomes the dominant strain of the virus in late 2021, the need to characterize and understand the difference between the new variant and its predecessors has been an increasing priority for public health authorities. Artificial Intelligence has played a significant role in the analysis of various facets of COVID-19 since the early stages of the pandemic. This study proposes the use of AI, specifically an XGBoost model, to quantify the impact of various medical risk factors (or “population features”) on the possibility of a patient outcome resulting in hospitalization, ICU admission, or death. The results are compared between the Delta and Omicron COVID-19 variants. Results indicated that older age and an unvaccinated patient status most consistently correspond as the most significant population features contributing to all three scenarios (hospitalization, ICU, death). The top 15 features for each variant-outcome scenario were determined, which most frequently included diabetes, cardiovascular disease, chronic kidney disease, and complications of pneumonia as highly significant population features contributing to serious illness outcomes. The Delta/Hospitalization model returned the highest performance metric scores for the area under the receiver operating characteristic (AUROC), F1, and Recall, while Omicron/ICU and Omicron/Hospitalization had the highest accuracy and precision values, respectively. The recall was found to be above 0.60 in most cases (with only two exceptions), indicating that the total number of false positives was generally minimized (accounting for more of the people who would theoretically require medical care). |
format | Online Article Text |
id | pubmed-9748260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97482602022-12-15 Use of AI to assess COVID-19 variant impacts on hospitalization, ICU, and death Hilal, Waleed Chislett, Michael G. Snider, Brett McBean, Edward A. Yawney, John Gadsden, S. Andrew Front Artif Intell Artificial Intelligence The rapid spread of COVID-19 and its variants have devastated communities worldwide, and as the highly transmissible Omicron variant becomes the dominant strain of the virus in late 2021, the need to characterize and understand the difference between the new variant and its predecessors has been an increasing priority for public health authorities. Artificial Intelligence has played a significant role in the analysis of various facets of COVID-19 since the early stages of the pandemic. This study proposes the use of AI, specifically an XGBoost model, to quantify the impact of various medical risk factors (or “population features”) on the possibility of a patient outcome resulting in hospitalization, ICU admission, or death. The results are compared between the Delta and Omicron COVID-19 variants. Results indicated that older age and an unvaccinated patient status most consistently correspond as the most significant population features contributing to all three scenarios (hospitalization, ICU, death). The top 15 features for each variant-outcome scenario were determined, which most frequently included diabetes, cardiovascular disease, chronic kidney disease, and complications of pneumonia as highly significant population features contributing to serious illness outcomes. The Delta/Hospitalization model returned the highest performance metric scores for the area under the receiver operating characteristic (AUROC), F1, and Recall, while Omicron/ICU and Omicron/Hospitalization had the highest accuracy and precision values, respectively. The recall was found to be above 0.60 in most cases (with only two exceptions), indicating that the total number of false positives was generally minimized (accounting for more of the people who would theoretically require medical care). Frontiers Media S.A. 2022-11-30 /pmc/articles/PMC9748260/ /pubmed/36530359 http://dx.doi.org/10.3389/frai.2022.927203 Text en Copyright © 2022 Hilal, Chislett, Snider, McBean, Yawney and Gadsden. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Artificial Intelligence Hilal, Waleed Chislett, Michael G. Snider, Brett McBean, Edward A. Yawney, John Gadsden, S. Andrew Use of AI to assess COVID-19 variant impacts on hospitalization, ICU, and death |
title | Use of AI to assess COVID-19 variant impacts on hospitalization, ICU, and death |
title_full | Use of AI to assess COVID-19 variant impacts on hospitalization, ICU, and death |
title_fullStr | Use of AI to assess COVID-19 variant impacts on hospitalization, ICU, and death |
title_full_unstemmed | Use of AI to assess COVID-19 variant impacts on hospitalization, ICU, and death |
title_short | Use of AI to assess COVID-19 variant impacts on hospitalization, ICU, and death |
title_sort | use of ai to assess covid-19 variant impacts on hospitalization, icu, and death |
topic | Artificial Intelligence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748260/ https://www.ncbi.nlm.nih.gov/pubmed/36530359 http://dx.doi.org/10.3389/frai.2022.927203 |
work_keys_str_mv | AT hilalwaleed useofaitoassesscovid19variantimpactsonhospitalizationicuanddeath AT chislettmichaelg useofaitoassesscovid19variantimpactsonhospitalizationicuanddeath AT sniderbrett useofaitoassesscovid19variantimpactsonhospitalizationicuanddeath AT mcbeanedwarda useofaitoassesscovid19variantimpactsonhospitalizationicuanddeath AT yawneyjohn useofaitoassesscovid19variantimpactsonhospitalizationicuanddeath AT gadsdensandrew useofaitoassesscovid19variantimpactsonhospitalizationicuanddeath |